President Donald Trump has issued an executive order aimed at tackling high drug prices in the United States, sparking concern and volatility across the global pharmaceutical industry. The announcement marks
All posts tagged in pharmaceutical industry2- Page
45Articles
AstraZeneca, the FTSE 100 pharmaceutical giant, has reaffirmed its full-year forecasts despite posting mixed first-quarter results and grappling with potential headwinds in major markets. The company reported a 10 per
The American pharmaceutical giant Pfizer has discontinued the development of its experimental weight-loss pill following safety concerns, marking a significant setback in its pursuit of the lucrative anti-obesity market, estimated
UK Government Accelerates Clinical Trials and Improves Access to NHS Data The United Kingdom government has unveiled ambitious plans aimed at enhancing the speed of clinical trials and facilitating greater
Keir Starmer has announced a series of significant measures aimed at bolstering the car and pharmaceutical sectors as the UK grapples with a shifting global landscape following Donald Trump’s imposition
Investment in Britain’s vital life sciences sector is under threat due to a deteriorating commercial environment. Senior executives from major pharmaceutical companies, including Johnson & Johnson, are voicing concerns that
Britain’s largest pharmaceutical companies have raised urgent concerns over what they describe as an “excessive” NHS sales rebate, warning it is harming investment in an economically crucial sector. Industry leaders
The activist investor DBay Advisors is set to take Alliance Pharma private with a final, sweetened offer of £362 million. The Isle of Man-based investment firm has increased its cash
British online pharmacies have witnessed extraordinary growth, with some providers reporting up to 300% increase in demand, primarily driven by the surging popularity of weight-loss medications. Market analysis from SpendMapper
British pharmaceutical giant GSK has announced its first share buyback programme in over a decade, committing £2 billion to the initiative whilst simultaneously upgrading its long-term sales projections. The FTSE
British pharmaceutical giant AstraZeneca has abandoned its £450 million expansion plans for its vaccine manufacturing facility in Speke, Liverpool, delivering a significant blow to the UK’s life sciences sector. The
Danish pharmaceutical giant Novo Nordisk, Europe’s most valuable listed company, has received a stern reprimand from the Prescription Medicines Code of Practice Authority (PMCPA) for systematically failing to disclose healthcare
British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a Massachusetts-based biopharmaceutical company, strengthening its position in the oncology sector. The FTSE
In a significant move that marks the largest biotech acquisition since 2023, Johnson & Johnson has announced its agreement to purchase neuroscience drugmaker Intra-Cellular Therapies for £14.6 billion. The New
In a devastating blow to investor confidence, Moderna’s shares experienced a dramatic decline of up to 22 per cent on Monday following disappointing sales forecasts from the US biotech giant.
Liverpool’s burgeoning life sciences sector is positioning itself as one of Europe’s premier biotech clusters, with projections indicating up to £800 million in investment over the next decade. The region’s
